Medtronic infusion set recall
This article was originally published in The Gray Sheet
Medtronic is recalling specific lots of its Quick-set infusion set used with the MiniMed Paradigm insulin pumps; the set is a replaceable plastic tube that delivers insulin from the pump to the diabetes patient. Medtronic recently discovered that about 2% of the sets in a lot of about 60,000 may not allow the pump to vent air properly, which could cause the device to deliver the wrong amount of insulin. Medtronic is advising patients to check 1www.medtronicdiabetes.com to see which box numbers are being recalled. The company will replace the affected products for free. Medtronic estimates about 3 million Quick-set sets are currently with customers
You may also be interested in...
Pandemic flu test: FDA granted emergency use authorization July 24 to a third diagnostic test for detecting the HINI pandemic flu virus, Quest Diagnostics Focus Diagnostics Influenza H1N1 (2009) real-time reverse transcription polymerase chain reaction test. The authorization, enabled by the 2004 Project BioShield law, permits Quest to distribute the test to clinical labs from its California-based Focus Diagnostics subsidiary. The assay can amplify viral genetic material obtained from nose or throat swabs, or nasal discharges, in patients with symptoms of respiratory infection. The previous two EUA tests were developed by the federal government
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.